Select Medical Holdings Stock EBITDA
| S24 Stock | EUR 19.80 0.30 1.54% |
Select Medical Holdings fundamentals help investors to digest information that contributes to Select Medical's financial success or failures. It also enables traders to predict the movement of Select Stock. The fundamental analysis module provides a way to measure Select Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Select Medical stock.
Select |
Select Medical Holdings Company EBITDA Analysis
Select Medical's EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Current Select Medical EBITDA | 635.51 M |
Most of Select Medical's fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Select Medical Holdings is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
| Competition |
According to the company disclosure, Select Medical Holdings reported earnings before interest,tax, depreciation and amortization of 635.51 M. This is 27.57% lower than that of the Healthcare sector and 13.1% lower than that of the Medical Care industry. The ebitda for all Germany stocks is 83.7% higher than that of the company.
Select EBITDA Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Select Medical's direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Select Medical could also be used in its relative valuation, which is a method of valuing Select Medical by comparing valuation metrics of similar companies.Select Medical is currently under evaluation in ebitda category among its peers.
Select Fundamentals
| Return On Equity | 0.14 | |||
| Return On Asset | 0.0316 | |||
| Profit Margin | 0.03 % | |||
| Operating Margin | 0.06 % | |||
| Current Valuation | 7.52 B | |||
| Shares Outstanding | 126.98 M | |||
| Shares Owned By Insiders | 18.39 % | |||
| Shares Owned By Institutions | 82.44 % | |||
| Price To Earning | 13.69 X | |||
| Price To Book | 2.72 X | |||
| Price To Sales | 0.46 X | |||
| Revenue | 6.33 B | |||
| Gross Profit | 1.1 B | |||
| EBITDA | 635.51 M | |||
| Net Income | 158.99 M | |||
| Cash And Equivalents | 147.82 M | |||
| Cash Per Share | 1.09 X | |||
| Total Debt | 3.84 B | |||
| Debt To Equity | 248.40 % | |||
| Current Ratio | 1.19 X | |||
| Book Value Per Share | 8.82 X | |||
| Cash Flow From Operations | 284.82 M | |||
| Earnings Per Share | 1.22 X | |||
| Target Price | 47.0 | |||
| Number Of Employees | 37.8 K | |||
| Beta | 1.38 | |||
| Market Capitalization | 3.33 B | |||
| Total Asset | 7.67 B | |||
| Annual Yield | 0.02 % | |||
| Net Asset | 7.67 B | |||
| Last Dividend Paid | 0.5 |
About Select Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Select Medical Holdings's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Select Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Select Medical Holdings based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in Select Stock
When determining whether Select Medical Holdings is a strong investment it is important to analyze Select Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Select Medical's future performance. For an informed investment choice regarding Select Stock, refer to the following important reports:Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Select Medical Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.